Global Clinical Safety and Pharmacovigilance Services Market Growth (Status and Outlook) 2024-2030

Global Clinical Safety and Pharmacovigilance Services Market Growth (Status and Outlook) 2024-2030

Clinical Safety and Pharmacovigilance Services encompass the processes and activities dedicated to ensuring the safety of pharmaceutical products and medical devices throughout their lifecycle. This includes monitoring and managing adverse events during clinical trials, post-marketing surveillance, signal detection, risk-benefit assessments, and compliance with regulatory requirements. These services aim to protect patients, maintain product integrity, and ensure adherence to safety regulations by identifying, assessing, and mitigating potential risks associated with medical treatments.

The global Clinical Safety and Pharmacovigilance Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Clinical Safety and Pharmacovigilance Services Industry Forecast” looks at past sales and reviews total world Clinical Safety and Pharmacovigilance Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Safety and Pharmacovigilance Services sales for 2023 through 2029. With Clinical Safety and Pharmacovigilance Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Safety and Pharmacovigilance Services industry.

This Insight Report provides a comprehensive analysis of the global Clinical Safety and Pharmacovigilance Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Safety and Pharmacovigilance Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Safety and Pharmacovigilance Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Safety and Pharmacovigilance Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Safety and Pharmacovigilance Services.

United States market for Clinical Safety and Pharmacovigilance Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Clinical Safety and Pharmacovigilance Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Clinical Safety and Pharmacovigilance Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Clinical Safety and Pharmacovigilance Services players cover SGS, PPD, ICON, IQVIA, Accenture, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Safety and Pharmacovigilance Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Clinical Study Safety Services
Post-Marketing Pharmacovigilance Services

Segmentation by Application:
Pharmaceutical Companies
Biotechnology Firms
Medical Device Manufacturers
Academic and Research Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Clinical Study Safety Services
Post-Marketing Pharmacovigilance Services

Segmentation by Application:
Pharmaceutical Companies
Biotechnology Firms
Medical Device Manufacturers
Academic and Research Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SGS
PPD
ICON
IQVIA
Accenture
Syneos Health
Clarivate
Wipro
HCLTech
Medpace
ProPharma
Lambda Therapeutic Research
PVpharm
George Clinical
PharmaLex
Parexel
CTI
UBC
Biomapas
Aixial Group
Worldwide Clinical Trials
Biotrial
PrimeVigilance
MMS Holdings
TransPerfect Life Sciences
Amarex
Precision for Medicine
Sitero
Medfiles
Arriello
TFS HealthScience
Pivotal
Quanticate
Veristat
WuXi AppTec
Tigermed

Please note: The report will take approximately 2 business days to prepare and deliver.